# Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems

> **NCT00547625** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 275 (actual)

## Conditions studied

- Prostatic Hyperplasia
- Prostate

## Interventions

- **DRUG:** tadalafil
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00547625
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2007-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00547625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00547625, "Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00547625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*